Cleared Traditional

K191125 - ADAS 3D

K191125 is the FDA 510(k) clearance for ADAS 3D by Galgo Medical S.L. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 261-day FDA review.

K191125 · Galgo Medical S.L · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2020
Decision
261d
Days
Class 2
Risk

K191125 is an FDA 510(k) clearance for the ADAS 3D. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Galgo Medical S.L (Barcelona, ES). The FDA issued a Cleared decision on January 15, 2020 after a review of 261 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Galgo Medical S.L devices

Submission Details

510(k) Number K191125 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 29, 2019
Decision Date January 15, 2020
Days to Decision 261 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
154d slower than avg
Panel avg: 107d · This submission: 261d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1056
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K191125.
FlightPlan for Embolization
K193261 · GE Medical Systems SCS · Jan 2020
Elements Viewer
K191014 · Brainlab AG · Jan 2020
EzMobile
K192098 · Ewoosoft Co., Ltd. · Jan 2020
ViewPoint 6
K192917 · Ge Medical Systems Ultrasound And · Jan 2020
AutoMIStar
K192912 · Apollo Medical Imaging Technology Pty. , Ltd. · Dec 2019
True 3D Viewer Software
K193149 · Echopixel, Inc. · Dec 2019